Marinus Pharmaceuticals, Inc. (MRNS)

Last Three Months

20-Jan-24 -- 19-Apr-24

Time Period:

Three Months
|
Year

($215.41K) Net Amount

Buy:	0	--
Sell:	($215.41K)	$9.56 - $9.98

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

23

0

1

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
21-Feb-24 4:06 PM View:	16-Feb-24 Market Sale (Planned) ($28.08K)	Hulihan Joseph Chief Medical Officer		Marinus Pharmaceuticals, Inc. - MRNS	(4%) 69.45K to 66.64K	0	($28.08K) (4%)	--	$9.98	Show Txns Hide Txns

27-Mar-24 11:55 AM View:	27-Mar-24 Option Exercise $214.00K	Braunstein Scott Chairman and CEO Director		Marinus Pharmaceuticals, Inc. - MRNS	16% 235.36K to 273.51K	0	($117.79K) (5%)	--	$9.94	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($20.58K)	Shafer Christina Chief Commercial Officer		Marinus Pharmaceuticals, Inc. - MRNS	(3%) 62.46K to 60.31K	0	($20.58K) (3%)	--	$9.56	Show Txns Hide Txns

22-Feb-24 4:05 PM View:	20-Feb-24 Market Sale (Planned) ($18.13K)	Manning Martha E SVP, GEN. COUNSEL & CORP. SEC.		Marinus Pharmaceuticals, Inc. - MRNS	(3%) 54.86K to 52.97K	0	($18.13K) (3%)	--	$9.57	Show Txns Hide Txns

21-Feb-24 4:05 PM View:	16-Feb-24 Market Sale (Planned) ($30.83K)	Pfanstiel Steven CFO AND COO		Marinus Pharmaceuticals, Inc. - MRNS	(4%) 74.79K to 71.7K	0	($30.83K) (4%)	--	$9.97	Show Txns Hide Txns